These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38057783)

  • 21. Association of stress hyperglycemia ratio and poor long-term prognosis in patients with myocardial infarction with non-obstructive coronary arteries.
    Abdu FA; Galip J; Qi P; Zhang W; Mohammed AQ; Liu L; Yin G; Mohammed AA; Mareai RM; Jiang R; Xu Y; Che W
    Cardiovasc Diabetol; 2023 Jan; 22(1):11. PubMed ID: 36647062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The stress hyperglycaemia ratio is associated with left ventricular remodelling after first acute ST-segment elevation myocardial infarction.
    Meng S; Zhu Y; Liu K; Jia R; Nan J; Chen M; Lei X; Zou K; Jin Z
    BMC Cardiovasc Disord; 2021 Feb; 21(1):72. PubMed ID: 33541271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between stress hyperglycaemic ratio and incidence of in-hospital cardiac arrest in patients with acute coronary syndrome: a retrospective cohort study.
    Li K; Yang X; Li Y; Xu G; Ma Y
    Cardiovasc Diabetol; 2024 Feb; 23(1):59. PubMed ID: 38336786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High stress hyperglycemia ratio predicts adverse clinical outcome in patients with coronary three-vessel disease: a large-scale cohort study.
    Qiao Z; Bian X; Song C; Zhang R; Yuan S; Lin Z; Zhu C; Liu Q; Ma W; Dou K
    Cardiovasc Diabetol; 2024 Jun; 23(1):190. PubMed ID: 38824608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of glycated hemoglobin among patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis.
    Li G; Hou X; Li Y; Zhang P; Zhao Q; Li J; Shi J
    Clin Chem Lab Med; 2017 Jul; 55(8):1090-1099. PubMed ID: 27816956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.
    Miyachi H; Takagi A; Miyauchi K; Yamasaki M; Tanaka H; Yoshikawa M; Saji M; Suzuki M; Yamamoto T; Shimizu W; Nagao K; Takayama M
    Heart Vessels; 2016 Nov; 31(11):1740-1751. PubMed ID: 26758733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment and validation of nomogram model for predicting major adverse cardiac events in patients with acute ST-segment elevation myocardial infarction based on glycosylated hemoglobin A1c to apolipoprotein A1 ratio: An observational study.
    Zhang KP; Guo QC; Mu N; Liu CH
    Medicine (Baltimore); 2024 Jun; 103(24):e38563. PubMed ID: 38875361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry.
    Bailleul C; Aissaoui N; Cayla G; Dillinger JG; Jouve B; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E;
    Arch Cardiovasc Dis; 2018 Feb; 111(2):101-108. PubMed ID: 28939193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of MELD-XI in elderly patients with ST-segment elevation myocardial infarction: an observational study.
    He SJ; Weng JX; Chen HJ; Li HQ; Guo WQ; Cao Q; Xu S; Yan HB; Peng CN
    BMC Cardiovasc Disord; 2021 Jan; 21(1):53. PubMed ID: 33509076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy.
    Falkentoft AC; Rørth R; Iversen K; Høfsten DE; Kelbæk H; Holmvang L; Frydland M; Schoos MM; Helqvist S; Axelsson A; Clemmensen P; Jørgensen E; Saunamäki K; Tilsted HH; Pedersen F; Torp-Pedersen C; Kofoed KF; Goetze JP; Engstrøm T; Køber L
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29776961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of mortality in patients with non-anterior ST-segment elevation myocardial infarction: Analysis from the HORIZONS-AMI trial.
    Huang X; Redfors B; Chen S; Gersh BJ; Mehran R; Zhang Y; McAndrew T; Ben-Yehuda O; Mintz GS; Stone GW
    Catheter Cardiovasc Interv; 2019 Aug; 94(2):172-180. PubMed ID: 30690854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship Between Troponin on Presentation and In-Hospital Mortality in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Wanamaker BL; Seth MM; Sukul D; Dixon SR; Bhatt DL; Madder RD; Rumsfeld JS; Gurm HS
    J Am Heart Assoc; 2019 Oct; 8(19):e013551. PubMed ID: 31547767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemoglobin A1c as a prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction.
    Cicek G; Uyarel H; Ergelen M; Ayhan E; Abanonu GB; Eren M; Gibson CM
    Coron Artery Dis; 2011 May; 22(3):131-7. PubMed ID: 21394027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of initial glycosylated hemoglobin level on cardiovascular outcomes in prediabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shin D; Ahn J; Cha KS; Park JS; Oh JH; Lee HW; Hong JY; Kim BW; Hong TJ;
    Coron Artery Dis; 2016 Jan; 27(1):40-6. PubMed ID: 26398151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of random blood glucose versus fasting blood glucose on in-hospital adverse events in patients with ST-segment elevation acute myocardial infarction.
    Qin Y; Yan G; Qiao Y; Wang D; Luo E; Hou J; Tang C
    BMC Cardiovasc Disord; 2020 Feb; 20(1):95. PubMed ID: 32103724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between glucose-related variables and plaque morphology in patients with ST-segment elevated myocardial infarction.
    Liu J; Wang S; Cui C; Cai H; Sun R; Pan W; Fang S; Yu B
    Cardiovasc Diabetol; 2020 Jul; 19(1):109. PubMed ID: 32641042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention].
    Ji C; Song F; Huang X; Qu X; Qiu N; Zhu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar; 35(3):299-304. PubMed ID: 36916344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged Hyperglycemia and Renal Failure after Primary Percutaneous Coronary Intervention.
    Izkhakov E; Rozenbaum Z; Margolis G; Khoury S; Keren G; Shacham Y
    Cardiorenal Med; 2019; 9(2):92-99. PubMed ID: 30636246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Significance of Relative Hyperglycemia after Percutaneous Coronary Intervention in Patients with and without Recognized Diabetes.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Curr Vasc Pharmacol; 2021; 19(1):91-101. PubMed ID: 32183677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention.
    Timmer JR; Hoekstra M; Nijsten MW; van der Horst IC; Ottervanger JP; Slingerland RJ; Dambrink JH; Bilo HJ; Zijlstra F; van 't Hof AW
    Circulation; 2011 Aug; 124(6):704-11. PubMed ID: 21768543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.